Heart valve showdown: which new device works best?

NCT ID NCT07545369

First seen May 09, 2026 · Last updated May 16, 2026 · Updated 1 time

Summary

This study compares two advanced artificial heart valves (SAPIEN 3 Ultra Resilia and Evolut FX) used in a procedure called TAVI to treat severe aortic stenosis. About 200 people with severe, symptomatic aortic stenosis will be randomly assigned to receive one of the two valves. The main goal is to see which valve works better at 30 days after the procedure, looking at success rate and how well the valve functions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEVERE AORTIC VALVE STENOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Assiut University Heart Hospital

    Asyut, Assiut Governorate, 71515, Egypt

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.